HCPCS Code G2206

Patient received adjuvant treatment course including both chemotherapy and her2-targeted therapy
Code effective Jan 01, 2021

HCPCS Section
Procedures/Professional Services (Temporary Codes)

G2206 is a valid 2026 HCPCS code meaning Patient received adjuvant treatment course including both chemotherapy and her2-targeted therapy or (Adjv trtmt chemo her2) for short. HCPCS G2206 has been effective since 01/01/2021 and applies to Medical care.


HCPCS Code Details - G2206

HCPCS Level II Code
Section G - Procedures/Professional Services (Temporary Codes)
HCPCS Code G2206
Description

Long description:
Patient received adjuvant treatment course including both chemotherapy and her2-targeted therapy

Short description:
Adjv trtmt chemo her2

HCPCS Pricing indicator 00 - Physician Fee Schedule And Non-Physician Practitioners - Service not separately priced by part B (e.g., services not covered, bundled, used by Part A only, etc.)
Multiple pricing indicator 9 - Not applicable as HCPCS not priced separately by part B or value is not established
Coverage code C - Carrier judgment
BETOS2 code Z2 - Undefined codes
HCPCS Action code N - No maintenance for this code
Type of service 1 - Medical care
Effective date Effective Jan 01, 2021
Date added Added Jan 01, 2021

See also

  • HCPCS G2205 · Patients with pregnancy during adjuvant treatment course

  • HCPCS G2207 · Reason for not administering adjuvant treatment course including both chemotherapy and her2-targeted therapy (e.g. poor performance status (ecog 3-4; karnofsky <=50), cardiac contraindications, insufficient renal function, insufficient hepatic function, other active or secondary cancer diagnoses, other medical contraindications, patients who died during initial treatment course or transferred during or after initial treatment course)

1 Two-digit numeric codes are Level I code modifiers copyrighted© by the American Medical Association's Current Procedural Terminology (CPT).

2 BETOS stands for “Berenson-Eggers Type Of Service”


HCPCS Level II codes and descriptors are approved and maintained jointly by the alpha-numeric editorial panel (consisting of CMS, the Health Insurance Association of America, and the Blue Cross and Blue Shield Association). — Updated 6/23/2026

CPT® is a registered trademark of the American Medical Association (AMA). All rights reserved.